상세 보기
- Go, Ga-Yeon;
- Lee, Sang-Jin;
- Jo, Ayoung;
- Lee, Jaecheol;
- Seo, Dong-Wan;
- ... Kim, Yong Kee;
- ... Bae, Gyu-Un;
- 외 3명
WEB OF SCIENCE
29SCOPUS
31초록
Background: Ginsenoside Rg1 belongs to protopanaxatriol-type ginsenosides and has diverse pharmacological activities. In this report, we investigated whether Rg1 could upregulate muscular stem cell differentiation and muscle growth. Methods: C2C12 myoblasts, MyoD-transfected 10T1/2 embryonic fibroblasts, and HEK293T cells were treated with Rg1 and differentiated for 2 d, subjected to immunoblotting, immunocytochemistry, or immunoprecipitation. Results: Rg1 activated promyogenic kinases, p38MAPK (mitogen-activated protein kinase) and Akt signaling, that in turn promote the heterodimerization with MyoD and E proteins, resulting in enhancing myogenic differentiation. Through the activation of Akt/mammalian target of rapamycin pathway, Rg1 induced myotube growth and prevented dexamethasone-induced myotube atrophy. Furthermore, Rg1 increased MyoD-dependent myogenic conversion of fibroblast. Conclusion: Rg1 upregulates promyogenic kinases, especially Akt, resulting in improvement of myoblast differentiation and myotube growth. (C) 2017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.
키워드
- 제목
- Ginsenoside Rg1 from Panax ginseng enhances myoblast differentiation and myotube growth
- 저자
- Go, Ga-Yeon; Lee, Sang-Jin; Jo, Ayoung; Lee, Jaecheol; Seo, Dong-Wan; Kang, Jong-Sun; Kim, Si-Kwan; Kim, Su-Nam; Kim, Yong Kee; Bae, Gyu-Un
- 발행일
- 2017-10
- 유형
- Article
- 권
- 41
- 호
- 4
- 페이지
- 608 ~ 614